[go: up one dir, main page]

DE3788709D1 - Piperidin-Derivate, ihre Herstellung und Anwendung. - Google Patents

Piperidin-Derivate, ihre Herstellung und Anwendung.

Info

Publication number
DE3788709D1
DE3788709D1 DE87114648T DE3788709T DE3788709D1 DE 3788709 D1 DE3788709 D1 DE 3788709D1 DE 87114648 T DE87114648 T DE 87114648T DE 3788709 T DE3788709 T DE 3788709T DE 3788709 D1 DE3788709 D1 DE 3788709D1
Authority
DE
Germany
Prior art keywords
production
piperidine derivatives
piperidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87114648T
Other languages
English (en)
Other versions
DE3788709T2 (de
Inventor
Jorgen Drejer
Palle Jakobsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK523286A external-priority patent/DK523286D0/da
Priority claimed from DK323487A external-priority patent/DK323487D0/da
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE3788709D1 publication Critical patent/DE3788709D1/de
Application granted granted Critical
Publication of DE3788709T2 publication Critical patent/DE3788709T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE87114648T 1986-11-03 1987-10-07 Piperidin-Derivate, ihre Herstellung und Anwendung. Expired - Fee Related DE3788709T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK523286A DK523286D0 (da) 1986-11-03 1986-11-03 Piperidine forbindelser, deres fremstilling og anvendelse
DK323487A DK323487D0 (da) 1987-06-25 1987-06-25 Piperidin forbindelser, deres fremstilling og anvendelse

Publications (2)

Publication Number Publication Date
DE3788709D1 true DE3788709D1 (de) 1994-02-17
DE3788709T2 DE3788709T2 (de) 1994-04-28

Family

ID=26066954

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87114648T Expired - Fee Related DE3788709T2 (de) 1986-11-03 1987-10-07 Piperidin-Derivate, ihre Herstellung und Anwendung.

Country Status (14)

Country Link
US (3) US4877799A (de)
EP (1) EP0266574B1 (de)
JP (1) JP2633872B2 (de)
KR (1) KR880006193A (de)
AU (1) AU602735B2 (de)
CA (1) CA1323367C (de)
DE (1) DE3788709T2 (de)
ES (1) ES2061463T3 (de)
FI (1) FI92821C (de)
IE (1) IE66332B1 (de)
IL (1) IL84021A (de)
NZ (1) NZ222155A (de)
PH (1) PH24749A (de)
PT (1) PT86066B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK231088D0 (da) * 1988-04-28 1988-04-28 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US5017585A (en) * 1986-11-03 1991-05-21 Novo Nordisk A/S Method of treating calcium overload
AT391269B (de) * 1988-12-30 1990-09-10 Burghart Kurt Pharmazeutische zubereitung
DK640289D0 (da) * 1989-12-18 1989-12-18 Ferrosan As Ny heterocyklisk kemi
IL98757A (en) * 1990-07-18 1997-01-10 Novo Nordisk As Piperidine derivatives their preparation and pharmaceutical compositions containing them
GB9226111D0 (en) * 1992-12-15 1993-02-10 Smithkline Beecham Plc Madicaments
ES2102295B1 (es) * 1994-03-18 1998-04-01 Ferrer Int Nuevos compuestos derivados de la n-benzoilmetil-piperidina.
JP3935502B2 (ja) * 1995-02-28 2007-06-27 第一アスビオファーマ株式会社 アリールピペリジン及びアリールピペラジン誘導体並びにそれらを含む医薬
JPH11505229A (ja) * 1995-05-17 1999-05-18 ノボ ノルディスク アクティーゼルスカブ ４−アリール−ピペリジン誘導体を製造する方法
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
JP3446468B2 (ja) 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
JP3882224B2 (ja) 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
EP1384711A1 (de) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Optische Trennung eines Piperidin-Derivates
AU710594B2 (en) * 1996-07-22 1999-09-23 Asubio Pharma Co., Ltd. Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the same
WO1998003172A1 (en) * 1996-07-22 1998-01-29 Suntory Limited Arylpiperidinol and arylpiperidine derivatives and drugs containing the same
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
US6110937A (en) * 1997-04-03 2000-08-29 Syntex Usa, Inc. Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain
ES2329739T3 (es) 1997-04-07 2009-11-30 Georgetown University Analogos de cocaina.
ATE200781T1 (de) * 1997-06-10 2001-05-15 Synthon Bv 4-phenylpiperidin-derivate
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
WO2002022572A2 (en) * 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
WO2005041875A2 (en) * 2003-10-22 2005-05-12 Georgetown University Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203149A (en) * 1968-06-10 1970-08-26 Ici Ltd Piperidine derivatives
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE2549999A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Piperidin-derivate und verfahren zu ihrer herstellung
DK149624C (da) * 1983-03-07 1987-02-02 Ferrosan As Fremgangsmaade til fremstilling af (+)-trans-3-((4-methoxyphenoxy)-methyl)-1-methyl-4-phenylpiperidin eller et farmaceutisk acceptabelt salt heraf ud fra en blanding af enantiomererne
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
US4593036A (en) * 1984-02-07 1986-06-03 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-[(4-methoxyphenoxy)methyl]-1-methylpiperidine useful as 5-HT potentiator
GB8431478D0 (en) * 1984-12-13 1985-01-23 Beecham Group Plc Compounds
EP0223403B1 (de) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use

Also Published As

Publication number Publication date
ES2061463T3 (es) 1994-12-16
FI874459A0 (fi) 1987-10-09
KR880006193A (ko) 1988-07-22
US5019582A (en) 1991-05-28
JP2633872B2 (ja) 1997-07-23
IL84021A (en) 1993-02-21
US4877799A (en) 1989-10-31
NZ222155A (en) 1990-08-28
PH24749A (en) 1990-10-01
AU602735B2 (en) 1990-10-25
FI92821C (fi) 1995-01-10
IL84021A0 (en) 1988-02-29
EP0266574A3 (en) 1988-07-20
AU8048287A (en) 1988-05-05
PT86066A (en) 1987-12-01
FI874459A7 (fi) 1988-05-04
US4985446A (en) 1991-01-15
DE3788709T2 (de) 1994-04-28
IE66332B1 (en) 1995-12-27
EP0266574A2 (de) 1988-05-11
CA1323367C (en) 1993-10-19
FI92821B (fi) 1994-09-30
JPS63126866A (ja) 1988-05-30
PT86066B (pt) 1990-11-07
EP0266574B1 (de) 1994-01-05
IE872561L (en) 1988-05-03

Similar Documents

Publication Publication Date Title
DE3788709D1 (de) Piperidin-Derivate, ihre Herstellung und Anwendung.
ATE89560T1 (de) Makrolid-derivate, ihre herstellung und ihre verwendung.
ATE123030T1 (de) Piperidin-derivate, ihre herstellung und ihre verwendung.
DE3684948D1 (de) Imidderivate, ihre herstellung und anwendung.
DE3486009D1 (de) 5-pyridyl-1,3-thiazol-derivate, ihre herstellung und anwendung.
DE3777366D1 (de) 2,3-dihydro-cumaron-derivate, ihre herstellung und verwendung.
DE3673047D1 (de) (imidazolyl-4)-piperidine, ihre herstellung und anwendung als heilmittel.
DE3885534D1 (de) Arylphosphorderivate, ihre Herstellung und Verwendung.
DE3578418D1 (de) Chinonderivate, ihre herstellung und verwendung.
DE3768922D1 (de) Anthrapyridon-verbindungen, ihre herstellung und ihre verwendung.
DE69008454D1 (de) Nitrolsothiolderivate, ihre Herstellung und Verwendung.
DE68907559D1 (de) Sulfoniumsalze, ihre anwendung und ihre herstellung.
DE3668891D1 (de) Benzothiazolone, ihre herstellung und anwendung.
ATA3589A (de) Neue isochinolinderivate, ihre herstellung und ihre verwendung
DE3765682D1 (de) Thiolactam-n-essigsaeure-derivate, ihre herstellung und verwendung.
DE3879024D1 (de) Pyridinium-derivate, ihre herstellung und verwendung.
DE68908313D1 (de) Klebverbaende, ihre herstellung und anwendung.
DE3777604D1 (de) Makrolid-verbindungen, ihre herstellung und ihre verwendung.
DE3784602D1 (de) Inonos-derivate, ihre herstellung und verwendung.
DE3773722D1 (de) Inosose-derivate und ihre herstellung.
DE3774718D1 (de) Benzothiazolylazolidine und ihre herstellung und verwendung.
DE3863191D1 (de) Substituierte aminderivate, ihre herstellung und verwendung.
DE3689919D1 (de) Polyfluorisoxazolamine, ihre Herstellung und Anwendung.
DE3677277D1 (de) (dihydro-4,5-1h-imidazolyl-2)-2-dihydro-2,3-indolderivate, ihre herstellung und anwendung als heilmittel.
DE68908389D1 (de) Amidofluoroverbindungen, ihre herstellung und ihre verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee